Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Tendinitis Treatment market within the Americas and Europe is undergoing dynamic changes encouraged by factors including an aging population, extended sports activities-related accidents, and advancements in clinical treatment options. This market encompasses numerous tendencies aimed at imparting effective and centered answers for individuals coping with tendinitis. The market trends are driven by a growing occurrence of tendinitis, specifically among most of the aging population and people engaged in sports. Sports-associated accidents, such as overuse of tendons, contribute substantially to the superiority of tendinitis in both the Americas and Europe. A first-rate trend is the focal point of regenerative remedy for Tendinitis Treatment. Stem mobile therapies, platelet-rich plasma (PRP) injections, and different regenerative approaches are gaining traction as they intend to promote tissue restoration and regeneration, supplying capability and long-term benefits for tendinitis patients.
The pharmaceutical sector is witnessing innovations in medications, in particular, those designed for Tendinitis Treatment. Anti-inflammatory capsules, pain relievers, and topical treatments are being developed to address the signs of tendinitis, presenting sufferers with centered relief. The market traits are leaning in the direction of precision remedy for tendinitis, thinking about individual variations in response to treatment. Tailoring interventions based on affected persons' unique factors, which include genetics and way of life, is becoming a key consideration for optimizing treatment results. Wearable generation plays a function in tendinitis control, especially in the tracking of bodily pastimes and biomechanics. These technologies offer real-time information, allowing healthcare carriers to customize treatment plans and music-affected person development more correctly. The adoption of telehealth services is growing, supplying patients within the Americas and Europe with the right of entry to faraway consultations with healthcare specialists. This trend complements the accessibility of Tendinitis Treatment, taking into consideration well-timed steering and follow-up appointments without the need for in-person visits.
The regulatory landscape is evolving, impacting the Tendinitis Treatment market. Stricter policies and compliance necessities ensure the protection and efficacy of treatments, fostering an extra transparent and responsible market for tendinitis treatments. While improvements are going on, challenges related to the value of Tendinitis Treatments persist. Market traits are step by step addressing those demanding situations, focusing on improving healthcare accessibility and affordability to reach a broader patient populace. Collaborative research efforts and ongoing medical trials are using innovation in Tendinitis Treatment. Partnerships among pharmaceutical businesses, studies establishments, and healthcare vendors boost the development of novel cures and make contributions to the growth of remedy alternatives. The market for tendinitis treatment within the Americas and Europe is poised for a continued boom, driven by an aggregate of improvements in regenerative medication and pharmaceutical improvements and a focal point on personalized care.
Tendinitis Treatment Industry Market Highlights:
Americas & Europe Tendinitis Treatment Market Overview
Americas & Europe Tendinitis Treatment Market Size was valued at USD 6.15 Billion in 2023. The Global Americas & Europe Tendinitis Treatment industry is projected to grow from USD 6.47 Billion in 2024 to USD 6.93 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.84% during the forecast period (2024 - 2032). Tendinitis is the inflammation of the tendon, thick cords that attache the muscles to the bone. The inflammation occurs as a result of sudden injury to the tendon, repetitive movement or disease condition such as diabetes, rheumatoid arthritis, gout, Reiter's syndrome or lupus.
In case of patients with gout, the uric acid crystals appear in the tendon sheath leading to friction. Tendinitis is found to be prevalent among athletes and is one of the common sport injuries in sport players, especially tennis, golf and others. Various pharmacological and non-pharmacological treatments are available for the treatment of tendinitis. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) constitute the preliminary treatment options. Other treatments including physical therapy, rest, and occupational therapy. Surgery is the last resort for tendinitis, and is only recommended in case of severe damage to the tendon that cannot be treated using pharmacological treatment options.
The market for tendinitis treatment is expected to grow at an exponential rate owing to increasing prevalence of sports injuries, rising geriatric population, increasing prevalence of patients suffering from diabetes and rheumatoid arthritis. Side effects of the treatment i.e. use of NSAIDs leading to stomach upset, and Gastrointestinal (GI) bleeding.
Intended Audience
- Tendinitis Treatment Manufacturers
- Tendinitis Treatment Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Americas & Europe Tendinitis Treatment Market Segmentation
The Americas & Europe tendinitis treatment market is segmented on the basis of type, treatment, and end user.
On the basis of type, the market is segmented into Achilles tendinitis, supraspinatus tendinitis, tennis or golfer's elbow, De Quervain's tenosynovitis, and others.
On the basis of treatment, the market is segmented into diagnosis, therapy, shock wave therapy or surgery, medical devices, devices, and others.
Diagnosis is further segmented into physical examination, imaging tests, ultrasound, Magnetic Resonance Imaging (MRI) Scans, and others.
Therapy is further segmented into non-pharmacological and pharmacological therapy. Non-pharmacological therapy includes rest therapy, heat & cold therapy, occupational therapy, physical therapy, and others. Pharmacological therapy includes OTC drugs or pain relievers, corticosteroids injections, platelet-rich plasma (PRP), and others.
Medical devices segment is further segmented mechanical band, support tape, pre-cut strips, continuous rolls, and others.
On the basis of end user, the market is segmented into hospitals & clinics, medical research centers, academic institutes, and others.
Regional Analysis of the Americas & Europe Tendinitis Treatment Market
America is the largest market for tendinitis treatment owing to an increasing demand for new treatment options for tendinitis, and rising prevalence of sport injuries and disease such as arthritis. Furthermore, increasing number of sport injuries also influence the growth of the market. Sports medicine, is now gaining roots in the developing, and the developed regions of America. In America, North America captures the largest share in the tendinitis treatment market.
According to the Center for Disease Control and Prevention, an estimated 78 million i.e. 26% of the U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. Additionally, the prevalence of tendinitis among athletes is found to be increasing from last few years in the U.S.
In Europe, the prevalence of diabetes and rheumatoid arthritis is on the rise. Furthermore, availability of funds for research and development activities in medical devices enhance the demand for technologically advanced devices for the diagnosis for tendinitis. Diabetes is one to the major risk factors for tendinitis. According to the report published by World Health Organization (WHO) in 2015, over 60 million people were suffering from diabetes in the European Region. Furthermore, lifestyle changes and lack of physical activity also influence the growth of this market in Europe. In Europe, Western European captures the largest share with German in leading position.
Recent Development
November 2023
Camber Pharmaceuticals expands its product portfolio with the inclusion of Naproxen Oral Suspension, which is indicated for treating the signs and symptoms of tendinitis. Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) that works by reducing inflammation and pain.Hyloris Pharmaceuticals announces that it has received FDA approval for its new drug, HY01, for the treatment of chronic tendinitis. HY01 is a hyaluronic acid (HA) injection that works by lubricating and cushioning the tendons.Ortho Clinical Diagnostics announces that it has launched a new test, the Ortho Clinical Diagnostics Tendinitis Panel, which can be used to diagnose and monitor tendinitis. The test measures the levels of three proteins that are involved in the development of tendinitis.
October 2023
A new study published in the journal Orthopaedics & Sports Physical Therapy finds that a combination of physical therapy and platelet-rich plasma (PRP) injections is effective in reducing pain and improving function in patients with tendinitis. PRP is a blood product that contains high concentrations of platelets, which are cells that play a role in healing.Another study published in the journal Pain Physician finds that a new type of corticosteroid injection, called triamcinolone acetonide microparticles (TA microparticles), is effective in reducing pain and improving function in patients with chronic tendinitis. TA microparticles are a long-acting form of corticosteroid that is released slowly over time.
September 2023
The American Academy of Orthopaedic Surgeons (AAOS) releases a new clinical practice guideline for the management of tendinitis. The guideline recommends a combination of physical therapy, NSAIDs, and other treatments, such as corticosteroid injections or PRP injections, depending on the severity of the condition.The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awards a grant to a team of researchers at the University of California, San Francisco to develop a new type of stem cell therapy for tendinitis. The therapy involves injecting stem cells into the affected tendon to promote healing.
Key Findings:
- By type, Achilles tendinitis acquired the largest market share in 2016.
- By treatment, diagnosis accounted for the largest market share in 2016 and is valued at USD 1200 million.
- By end user, hospitals & clinics accounted for the largest market share of 41.8% in the Americas & Europe tendinitis market, in 2016.
Key Players in the Americas & Europe Tendinitis Treatment Market
Some of the key players in this market are:
- Abbott (U.S.)
- Pfizer (U.S.)
- AstraZeneca (U.K)
- Bayer (Germany)
- Merck & Co. Inc. (Germany)
- GlaxoSmithKline plc (U.S.)
- Teva Pharmaceutical Industries (Israel)
- Boehringer Ingelheim Pharmaceuticals, Inc. (Germany)
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
